Scientific Program - Saturday 11 May

Print
 
Saturday 11 May, 2019   Sunday 12 May, 2019
 
Saturday 11 April, 2019
HALL A
09:00-10:30
Chairs:


09:00-09:15
09:15-09:30
09:30-09:45


09:45-10:00
10:00-10:15
10:15-10:30
Session 1 | Cardiovascular outcome in Diabetes
Su Benjil
, China, Mu Yiming, China and Antonio Ceriello, Italy

Is the CVO in CVOT's applicable for the Asian population?
Yes: Antonio Ceriello, Italy
No: Li Guangwei, China
Discussion

Prevention of cardiac events in primary prevention: Should we use SGLT2 or glucosidase inhibitors?
SGLT2: Itamar Raz, Israel
Glucosidase Inhibitors: Liu Jianmin, China
Discussion
HALL B
09:00-10:30
Chairs:


09:00-09:15
09:15-09:30
09:30-09:45

09:45-10:30

Session 2 | Management of Glucolipid Metabolism
Gu Weiqiong, China, Jiao Kai, China and Luc Van Gaal, Belgium

Should we treat NASH by drugs of surgery?
Yes: Luc Van Gaal, Belgium
No: Qu Shen, China
Discussion

Omega-3 fatty acids in glucolipid matabolism: Wang Weiqing, China
HALL C
09:00-10:30
Chairs:


09:00-09:15
09:15-09:30
09:30-09:45


09:45-10:00
10:00-10:15
10:15-10:30
Session 3 | Controversies of Antidiabetic Therapies
Liu Libin
, China, Chen Bing, China and Eberhard Standl, Germany

Should glucosidase inhibitors be the first drug in type 2 diabetic patients in Asia?
Yes: Wang Weiqing, China
No: Eberhard Standl, Germany
Discussion

Is SGLT2 a safe drug?
Yes: Philip Home, UK
No: Weng Jianping, China
Discussion
 
10:30-10:50
VISIT EXHIBITS & COFFEE BREAK
10:50-11:50 INDUSTRY SPONSORED SYMPOSIA A-C  
11:50-12:00  LUNCH BOX PICK UP 
12:00-13:00 INDUSTRY SPONSORED SYMPOSIA D-F 
HALL A
13:00-14:30
Chairs:


Session 4 | Focus on Basal Insulin: Initiation and combination
Zou Daijin
, China and Wang Weiqing, China 

The insulin initiation perios is essential to reach metabolic control in patients with T2DM: Feng Bo, China

The only GLP-1RA with basal insulin combination indication in China: Zou Dajin, China
HALL B
13:00-14:30
Chairs:


13:00-13:15
13:15-13:30
13:30-13:45


13:45-14:00
14:00-14:15
14:15-14:30
Session 5 | Kidney Protection and Islet Transplantation
Chen Gang
, China, Shan Zhongyan, China and Paolo Pozzilli, Italy

Can nephropathy be reversed?
Yes: Itamar Raz, Israel
No: Zheng Hongting, China
Discussion

Has pancreatic islet transplantation failed clinical expectations?
Yes: Paolo Pozzilli, Italy
No: Zhu Dalong, China
Discussion

 HALL C

13:00-14:30
Chairs:


13:00-13:15
13:15-13:30
13:30-13:45


13:45-14:00
14:00-14:15
14:15-14:30
Session 6 | Controversies of Novel Antidiabetic Therapies
Qin Fojas
, China, Tang Xulei, China and Mia C. Fojas, Philippines

Are bio similar insulins equal to originators?
Yes: Philip Home, UK
No: Li Yan, China
Discussion

Controversies in Diabetes in Asia
China: Teng Weiping, China
Rest of the World: Mia C. Fojas, Philippines
Discussion
 
14:30-15:30
15:30-15:45   VISIT EXHIBITS & COFFEE BREAK
PLENARY HALL
15:45-16:00
Chairs:
OPENING CEREMONY
Wang Weiqing
, China and Zhu Dalong, China

Welcome from the Congress Co-Chairs: Ning Guang, China and Itamar Raz, Israel
PLENARY HALL
16:00-18:00
Chairs

16:00-16:45
16:45-17:15
17:15-17:45
17:45-18:00
Welcome Session | Key Note Lectures
Ning Guang
, China and Itamar Raz, Israel

Synergism in health diabestes as a parable: Itamar Raz, Israel
The new biology of beta cell failure in diabetes: Domenico Accili, USA
AI – What exactly is it and how will it influence the Diabetes handling: Dov Moran, Israel
Discussion